Whole blood microRNA expression associated with stroke: Results from the Framingham Heart Study

PLoS One. 2019 Aug 8;14(8):e0219261. doi: 10.1371/journal.pone.0219261. eCollection 2019.

Abstract

Emerging evidence suggests microRNAs (miRNAs) may play an important role in explaining variation in stroke risk and recovery in humans, yet there are still few longitudinal studies examining the association between whole blood miRNAs and stroke. Accounting for multiple testing and adjusting for potentially confounding technical and clinical variables, here we show that whole blood miR-574-3p expression was significantly lower in participants with chronic stroke compared to non-cases. To explore the functional relevance of our findings, we analyzed miRNA-mRNA whole blood co-expression, pathway enrichment, and brain tissue gene expression. Results suggest miR-574-3p is involved in neurometabolic and chronic neuronal injury response pathways, including brain gene expression of DBNDD2 and ELOVL1. These results suggest miR-574-3p plays a role in regulating chronic brain and systemic cellular response to stroke and thus may implicate miR-574-3p as a partial mediator of long-term stroke outcomes.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Brain / metabolism
  • Fatty Acid Elongases / genetics
  • Fatty Acid Elongases / metabolism
  • Female
  • Gene Expression Profiling / methods
  • Humans
  • Longitudinal Studies
  • Male
  • MicroRNAs / blood
  • MicroRNAs / genetics*
  • MicroRNAs / metabolism
  • Middle Aged
  • Risk Factors
  • Stroke / genetics*
  • Transcriptome / genetics

Substances

  • ELOVL1 protein, human
  • MIRN574 microRNA, human
  • MicroRNAs
  • Fatty Acid Elongases